Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19. 9/7/22. Anderson AS. N Engl J Med. Using data from the EPIC-HR3 trial which compared nirmatrelvir-ritonavir to placebo in unvaccinated patients, the authors found that viral load rebound following...
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir. 12/6/22. Wong GL. JAMA Netw Open. To better understand the much-discussed rebound phenomena when COVID-19 patients receive oral antiviral medication (molnupiravir (Lagevrio) or...
Higher versus Lower Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose-Response Meta-analysis. 11/30/22. Pitre T. Ann Am Thorac Soc. According to this article, compared to lower-dose corticosteroids (6mg/day*10), higher-dose...
Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection. 12/12/22. Kwan AC. Nature Cardiovascular Research. Postural orthostatic tachycardia syndrome (POTS) has been previously described after COVID-19...
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents. 11/29/22. Dumont R. Nat Commun. This report is from a Swiss population study of 1,034 children, aged 6 months to 17 years, who were tested for...
